IMMUNE RESPONSE IN MALIGNANT GLIOMA

• Autori principali: Iliyan Koev (Autore), E. Slavov (Autore), D. Staykov (Autore), K. Halacheva (Autore), Victoria Sarafian (Autore)
• Natura: Libro
• Pubblicazione: Peytchinski Publishing, 2010-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Objective: Malignant gliomas are primary brain tumors with excessive mortality and high resistance to chemotherapy and radiotherapy. The survival time for glioblastoma multi­forme is about 6-12 months. As key pathogenetic mechanisms are recognized the massive necrosis, angiogenesis and hypoxia withi...